The differential effects of thiazolidindiones on atherogenic dyslipidemia in type 2 diabetes: what is the clinical significance?

Giovam Battista Rini, Manfredi Rizzo, Kaspar Berneis, Emanuel R. Christ, Giatgen A. Spinas

    Risultato della ricerca: Article

    17 Citazioni (Scopus)
    Lingua originaleEnglish
    pagine (da-a)2295-2303
    Numero di pagine9
    RivistaExpert Opinion on Pharmacotherapy
    Volume9
    Stato di pubblicazionePublished - 2008

    All Science Journal Classification (ASJC) codes

    • Pharmacology
    • Pharmacology (medical)

    Cita questo

    @article{bd91b9e1cd664be8a8da31cc6eb69c97,
    title = "The differential effects of thiazolidindiones on atherogenic dyslipidemia in type 2 diabetes: what is the clinical significance?",
    keywords = "Thiazolidindiones,Atherogenic dyslipidemia",
    author = "Rini, {Giovam Battista} and Manfredi Rizzo and Kaspar Berneis and Christ, {Emanuel R.} and Spinas, {Giatgen A.}",
    year = "2008",
    language = "English",
    volume = "9",
    pages = "2295--2303",
    journal = "Expert Opinion on Pharmacotherapy",
    issn = "1465-6566",
    publisher = "Informa Healthcare",

    }

    TY - JOUR

    T1 - The differential effects of thiazolidindiones on atherogenic dyslipidemia in type 2 diabetes: what is the clinical significance?

    AU - Rini, Giovam Battista

    AU - Rizzo, Manfredi

    AU - Berneis, Kaspar

    AU - Christ, Emanuel R.

    AU - Spinas, Giatgen A.

    PY - 2008

    Y1 - 2008

    KW - Thiazolidindiones,Atherogenic dyslipidemia

    UR - http://hdl.handle.net/10447/36379

    M3 - Article

    VL - 9

    SP - 2295

    EP - 2303

    JO - Expert Opinion on Pharmacotherapy

    JF - Expert Opinion on Pharmacotherapy

    SN - 1465-6566

    ER -